Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

VICPVicapsys Life Sciences, Inc.

OTC · CIK 0001468639
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts172

Identity from submissions API

NameVicapsys Life Sciences, Inc.
CIK0001468639
TickersVICP
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN621153426
LEI—
Fiscal year end1231
State of incorporationFL FL
Phone470-514-4013
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • SSGI, INC. (2009-07-17T00:00:00.000Z → 2016-11-07T00:00:00.000Z)
Business address
1735 BUFORD HIGHWAY
STE. 215-113
CUMMING
GA
30041
GA
Mailing address
1735 BUFORD HIGHWAY
STE. 215-113
CUMMING
GA
30041
GA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

92 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2025-03-27 15-12G form15-12g.htm 0001641172-25-000877 000-56145 25777002 34 18623
2025-03-21 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-043406 005-85123 25761863 34 110062
2025-03-21 3 3 0000950170-25-043405 8381
2025-01-10 10-Q form10-q.htm 0001493152-25-001779 000-56145 25523887 34 3508373 1 1
2025-01-10 10-Q form10-q.htm 0001493152-25-001776 000-56145 25523846 34 3435005 1 1
2025-01-10 10-Q form10-q.htm 0001493152-25-001743 000-56145 25523593 34 3189024 1 1
2024-10-21 10-K form10-k.htm 0001493152-24-041809 000-56145 241384207 34 5183084 1 1
2024-06-27 SEC STAFF ACTION filename1.pdf 9999999997-24-003035 6899
2023-12-27 8-K form8-k.htm 1.01,2.03,9.01 0001493152-23-046217 000-56145 231517202 34 231641 1 1
2023-11-14 10-Q form10-q.htm 0001493152-23-040951 000-56145 231404417 34 3652702 1 1
2023-08-14 10-Q form10-q.htm 0001493152-23-028151 000-56145 231167405 34 3543382 1 1
2023-08-09 DEF 14C def14c.htm 0001493152-23-027339 000-56145 231154967 34 182231
2023-07-28 PRE 14C formpre14c.htm 0001493152-23-025916 000-56145 231123850 34 182237
2023-07-13 D xslFormDX01/primary_doc.xml 06b 0001493152-23-024442 021-486774 231086349 33 10694
2023-06-30 S-1 forms-1.htm 0001493152-23-023181 333-273109 231064273 33 7187578 1 1
2023-06-30 8-K form8-k.htm 1.01,2.03,3.02,9.01 0001493152-23-023183 000-56145 231062859 34 615583 1 1
2023-06-02 8-K form8-k.htm 1.01,9.01 0001493152-23-019905 000-56145 23987822 34 286015 1 1
2023-05-18 8-K/A form8-ka.htm 4.01,9.01 0001493152-23-018151 000-56145 23937106 34 218181 1 1
2023-05-17 8-K form8-k.htm 4.01,9.01 0001493152-23-017970 000-56145 23932640 34 363594 1 1
2023-05-15 10-Q form10-q.htm 0001493152-23-017138 000-56145 23920675 34 3029541 1 1
2023-04-14 10-K form10-k.htm 0001493152-23-012267 000-56145 23820924 34 5223268 1 1
2023-03-31 NT 10-K formnt10-k.htm 0001493152-23-010247 000-56145 23787508 34 36871
2023-01-12 8-K form8-k.htm 5.02,9.01 0001493152-23-001296 000-56145 23526018 34 446194 1 1
2022-11-21 DEF 14C formdef14c.htm 0001493152-22-033087 000-56145 221405491 34 313444
2022-11-21 10-Q form10-q.htm 0001493152-22-033024 000-56145 221403882 34 3832626 1 1
2022-11-14 NT 10-Q formnt10q.htm 0001493152-22-032168 000-56145 221386880 34 36747
2022-09-28 8-K form8-k.htm 5.02 0001493152-22-027017 000-56145 221276087 34 208067 1 1
2022-08-16 10-Q form10-q.htm 0001493152-22-023207 000-56145 221170669 34 3642594 1 1
2022-08-15 NT 10-Q formnt10-q.htm 0001493152-22-022969 000-56145 221166676 34 37040
2022-05-17 DEF 14C formdef14c.htm 0001493152-22-014135 000-56145 22932948 34 185325
2022-05-13 10-Q form10-q.htm 0001493152-22-013375 000-56145 22923933 34 4630878 1 1
2022-05-06 PRE 14C formpre14c.htm 0001493152-22-012369 000-56145 22900709 34 185271
2022-04-12 8-K form8-k.htm 5.02,8.01,9.01 0001493152-22-009690 000-56145 22822309 34 220080 1 1
2022-03-16 10-K form10-k.htm 0001493152-22-006994 000-56145 22745371 34 4096884 1 1
2021-11-12 10-Q form10-q.htm 0001493152-21-027976 000-56145 211399267 34 3314941 1 1
2021-09-20 10-Q form10-q.htm 0001493152-21-023189 000-56145 211264180 34 3408866 1 1
2021-09-20 10-Q form10-q.htm 0001493152-21-023170 000-56145 211263963 34 2478567 1
2021-09-17 10-K form10-k.htm 0001493152-21-022984 000-56145 211260054 34 3983570 1
2021-09-13 10-Q form10-q.htm 0001493152-21-022517 000-56145 211249085 34 2899089 1
2021-09-09 10-Q form10-q.htm 0001493152-21-022270 000-56145 211244228 34 2983737 1
2020-05-15 10-Q form10-q.htm 0001493152-20-009028 000-56145 20883765 34 2301028 1
2020-04-06 UPLOAD filename1.pdf 0000000000-20-002930 39586
2020-03-30 10-12G/A form10-12ga.htm 0001493152-20-005283 000-56145 20758356 34 1524667
2020-03-27 UPLOAD filename1.pdf 0000000000-20-002683 42296
2020-03-20 CORRESP filename1.htm 0001493152-20-004429 55569
2020-03-20 10-12G/A form10-12ga.htm 0001493152-20-004426 000-56145 20731919 34 1954855
2020-03-11 UPLOAD filename1.pdf 0000000000-20-002161 57111
2020-02-12 10-12G form10-12g.htm 0001493152-20-002044 000-56145 20603501 34 25736488
2018-02-16 D xslFormDX01/primary_doc.xml 06b 0001716888-18-000001 021-305893 18621055 33 12947
2018-01-08 D xslFormDX01/primary_doc.xml 06b 0001475158-18-000001 021-302620 18515583 33 11560
2016-11-07 15-15D form15-15d.htm 0001493152-16-014543 333-160700 161976175 34 14956
2010-09-08 4 xslF345X03/v196190_ex.xml 0001144204-10-048603 6944
2010-08-24 10-Q v194949_10q.htm 0001144204-10-046358 333-160700 101034924 34 784022
2010-08-16 NT 10-Q v194163_12b-25.htm 0001144204-10-044269 333-160700 101018321 34 29751
2010-08-16 4 xslF345X03/v193357_ex.xml 0001144204-10-044155 7018
2010-07-29 8-K/A v191547_8ka.htm 2.01,9.01 0001144204-10-040083 333-160700 10978096 34 1321400
2010-07-01 8-K v189648_8k.htm 5.02,9.01 0001144204-10-036040 333-160700 10929649 34 28703
2010-06-22 10-Q v187901_10q.htm 0001144204-10-034513 333-160700 10910084 34 583453
2010-05-25 D xslFormDX01/primary_doc.xml 06 0001144204-10-030156 021-142513 10856017 33 9808
2010-05-24 10-K v185945_10k.htm 0001144204-10-029858 333-160700 10853729 34 1523349
2010-05-24 D xslFormDX01/primary_doc.xml 06 0001144204-10-029807 021-142456 10853385 33 9862
2010-05-20 SC 13G v185877_sc13g.htm 0001144204-10-029190 005-85123 10847254 34 43789
2010-05-20 3 xslF345X02/v185880_ex.xml 0001144204-10-029178 3736
2010-05-18 8-K v185727_8k.htm 2.01,3.02,9.01 0001144204-10-028744 333-160700 10841939 34 1080125
2010-05-17 NT 10-Q v185542_nt10q.txt 0001144204-10-028070 333-160700 10837269 34 6358
2010-04-26 8-K v182167_8k.htm 1.02,5.02 0001144204-10-022071 333-160700 10769623 34 23794
2010-04-12 8-K v180789_8k.htm 5.02,9.01 0001144204-10-019600 333-160700 10745525 34 24757
2010-04-02 NT 10-K/A v180027_nt10ka.htm 0001144204-10-018309 333-160700 10728300 34 40305
2010-04-01 NT 10-K v179783_nt10k.htm 0001144204-10-017956 333-160700 10723677 34 39908
2010-01-29 4/A xslF345X03/v172686_ex.xml 0001144204-10-004368 4612
2010-01-25 4 xslF345X03/v172120_ex.xml 0001144204-10-003360 14567
2009-12-22 SC 13D SCHEDULE 13D 0000950123-09-072385 005-85123 091253145 34 95252
2009-12-14 3/A xslF345X02/v168584_ex.xml 0001144204-09-064364 4344
2009-12-10 SC 13D v168732_sc13d.htm 0001144204-09-064053 005-85123 091234247 34 69912
2009-12-09 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2009-12-09 09:30:00 9999999995-09-003414 333-160700 091232146 33 2079
2009-12-09 8-K v168604_8k.htm 8.01,9.01 0001144204-09-063848 333-160700 091231256 34 55045
2009-12-09 3 xslF345X02/v168343_ex.xml 0001144204-09-063801 4787
2009-12-09 UPLOAD filename1.pdf 0000000000-09-069519 49101
2009-12-09 UPLOAD filename1.pdf 0000000000-09-069433 88727
2009-12-09 3 xslF345X02/v168337_ex.xml 0001144204-09-063763 3706
2009-12-09 3 xslF345X02/v168341_ex.xml 0001144204-09-063756 4224
2009-12-09 3 xslF345X02/v168340_ex.xml 0001144204-09-063740 4746
2009-12-09 3 xslF345X02/v168339_ex.xml 0001144204-09-063738 4141
2009-12-09 3 xslF345X02/v168338_ex.xml 0001144204-09-063736 5756
2009-12-09 3 xslF345X02/v168334_ex.xml 0001144204-09-063724 6476
2009-12-03 CORRESP filename1.htm 0001144204-09-062950 13145
2009-11-20 S-1/A v166988_s1a.htm 0001144204-09-061132 333-160700 091197924 33 3405594
2009-10-27 S-1/A v163537_s1a.htm 0001144204-09-054681 333-160700 091137884 33 3541222
2009-09-29 CORRESP filename1.htm 0001144204-09-050635 142702
2009-09-29 S-1/A v161152_s1a.htm 0001144204-09-050580 333-160700 091092913 33 50344027
2009-08-11 UPLOAD filename1.pdf 0000000000-09-043497 132137
2009-07-17 S-1 v154885_s1.htm 0001144204-09-037832 333-160700 09953458 33 21843002

Latest XBRL company facts

One latest value per concept from companyfacts (172 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 32.37M 2024-12-13 2024 Q1 10-Q 2025-01-10 0001493152-25-001743
dei EntityListingParValuePerShare Entity Listing, Par Value Per Share USD/shares 0.001 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
dei EntityPublicFloat Entity Public Float USD 4.66M 2024-06-30 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 537,449 2023-12-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 272,317 2022-12-31 2022 FY 10-K 2023-04-14 0001493152-23-012267
us-gaap AccountsPayableTradeCurrent Accounts Payable, Trade, Current USD 961,708 2023-12-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 115,312 2023-12-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 14.37M 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 14.07M 2022-09-30 2022 Q3 10-Q 2022-11-21 0001493152-22-033024
us-gaap AdjustmentForAmortization Amortization USD 27,844 2024-01-01 2024-03-31 2024 Q1 10-Q 2025-01-10 0001493152-25-001743
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 3,548 2022-01-01 2022-12-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 20,697 2023-01-01 2023-03-31 2024 Q1 10-Q 2025-01-10 0001493152-25-001743
us-gaap AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net USD 4,326 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-16 0001493152-22-006994
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 50,574 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 115,082 2023-01-01 2023-12-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits Dilutive Securities, Effect on Basic Earnings Per Share, Options and Restrictive Stock Units USD 2,163 2021-01-01 2021-03-31 2022 Q1 10-Q 2022-05-13 0001493152-22-013375
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 3.18M 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap Assets Assets USD 89,569 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap AssetsCurrent Assets, Current USD 89,569 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap Cash Cash USD 26,210 2022-09-30 2022 Q3 10-Q 2022-11-21 0001493152-22-033024
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 89,569 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 89,569 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 80,147 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 0 2023-12-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations Cash Provided by (Used in) Financing Activities, Discontinued Operations USD 176,600 2019-01-01 2019-12-31 2020 FY 10-K 2021-09-17 0001493152-21-022984
us-gaap CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations Cash Provided by (Used in) Operating Activities, Discontinued Operations USD -132,830 2019-01-01 2019-12-31 2020 FY 10-K 2021-09-17 0001493152-21-022984
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.5 2022-07-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 300.00M 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 32.37M 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 32.37M 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap CommonStockValue Common Stock, Value, Issued USD 32,371 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 50,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-09-17 0001493152-21-022984
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 597,281 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001493152-23-028151
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 511,403 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 328,571 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap DebtInstrumentAnnualPrincipalPayment Debt Instrument, Annual Principal Payment USD 363,000 2023-12-26 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 363,000 2023-12-26 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap DebtInstrumentFairValue Debt Instrument, Fair Value Disclosure USD 35,625 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap DebtInstrumentFeeAmount Debt Instrument, Fee Amount USD 83,526 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 50,441 2022-12-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 2.99M 2023-12-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 2.99M 2023-12-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap Depreciation Depreciation USD 30,364 2019-01-01 2019-12-31 2020 FY 10-K 2021-09-17 0001493152-21-022984
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic and Diluted Share USD/shares -0.03 2019-01-01 2019-12-31 2020 FY 10-K 2021-09-17 0001493152-21-022984
us-gaap DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities Disposal Group, Including Discontinued Operation, Accrued Liabilities USD 277,083 2018-12-31 2020 FY 10-K 2021-09-17 0001493152-21-022984
us-gaap DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense Disposal Group, Including Discontinued Operation, General and Administrative Expense USD 58,215 2019-01-01 2019-12-31 2020 FY 10-K 2021-09-17 0001493152-21-022984
us-gaap DisposalGroupIncludingDiscontinuedOperationOperatingExpense Disposal Group, Including Discontinued Operation, Operating Expense USD 425,787 2019-01-01 2019-12-31 2020 FY 10-K 2021-09-17 0001493152-21-022984
us-gaap DisposalGroupIncludingDiscontinuedOperationRevenue Disposal Group, Including Discontinued Operation, Revenue USD 50,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-09-17 0001493152-21-022984
us-gaap DueToRelatedPartiesCurrentAndNoncurrent Due to Related Parties USD 875,177 2020-12-31 2020 FY 10-K 2021-09-17 0001493152-21-022984
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.02 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.01 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-16 0001493152-22-006994
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.02 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2023-01-01 2023-12-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 0 2023-12-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.2 2022-03-31 2022 Q1 10-Q 2022-05-13 0001493152-22-013375
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 0 2022-12-31 2022 FY 10-K 2023-04-14 0001493152-23-012267
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 215,025 2021-12-31 2021 FY 10-K 2022-03-16 0001493152-22-006994
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 31,299 2022-09-30 2022 Q3 10-Q 2022-11-21 0001493152-22-033024
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 7,822 2022-09-30 2022 Q3 10-Q 2022-11-21 0001493152-22-033024
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 215,035 2022-09-30 2022 Q3 10-Q 2022-11-21 0001493152-22-033024
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 31,299 2022-09-30 2022 Q3 10-Q 2022-11-21 0001493152-22-033024
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 31,299 2022-09-30 2022 Q3 10-Q 2022-11-21 0001493152-22-033024
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 31,299 2022-09-30 2022 Q3 10-Q 2022-11-21 0001493152-22-033024
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 371,520 2021-12-31 2022 FY 10-K 2023-04-14 0001493152-23-012267
us-gaap FiniteLivedPatentsGross Finite-Lived Patents, Gross USD 492,514 2021-12-31 2022 FY 10-K 2023-04-14 0001493152-23-012267
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD 100,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-09-20 0001493152-21-023170
us-gaap GainLossOnSaleOfInvestments Gain (Loss) on Sale of Investments USD 100,000 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-09-20 0001493152-21-023189
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -86,300 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 41,819 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 340,231 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-14 0001493152-23-012267
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD 340,231 2022-01-01 2022-12-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -752,670 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -765,844 2020-01-01 2020-12-31 2020 FY 10-K 2021-09-17 0001493152-21-022984
us-gaap IncomeLossFromContinuingOperationsPerBasicAndDilutedShare Income (Loss) from Continuing Operations, Per Basic and Diluted Share USD/shares -0.1 2020-01-01 2020-12-31 2020 FY 10-K 2021-09-17 0001493152-21-022984
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -375,787 2019-01-01 2019-12-31 2020 FY 10-K 2021-09-17 0001493152-21-022984
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD 100,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-04-14 0001493152-23-012267
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 456 2023-01-01 2023-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 243,898 2023-01-01 2023-12-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 4,346 2023-01-01 2023-12-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -248,244 2023-01-01 2023-12-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 1.18M 2023-01-01 2023-12-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 26,208 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-13 0001493152-22-013375
us-gaap IncreaseDecreaseInAccountsPayableRelatedParties Increase (Decrease) in Accounts Payable, Related Parties USD 272,522 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD 269,353 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 115,312 2020-01-01 2020-12-31 2020 FY 10-K 2021-09-17 0001493152-21-022984
us-gaap IncreaseDecreaseInNotesPayableCurrent Increase (Decrease) in Notes Payable, Current USD -6,167 2024-01-01 2024-03-31 2024 Q1 10-Q 2025-01-10 0001493152-25-001743
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -30,234 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 1.06M 2021-01-01 2021-03-31 2022 Q1 10-Q 2022-05-13 0001493152-22-013375
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 2.68M 2021-01-01 2021-03-31 2022 Q1 10-Q 2022-05-13 0001493152-22-013375
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 371,520 2021-12-31 2022 FY 10-K 2023-04-14 0001493152-23-012267
us-gaap InterestExpense Interest Expense USD 10,660 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001493152-23-040951
us-gaap InterestExpenseDebt Interest Expense, Debt USD 5,156 2023-01-01 2023-12-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 81,412 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 212 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 16,626 2019-01-01 2019-03-31 2020 Q1 10-Q 2020-05-15 0001493152-20-009028
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 89,569 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap LiabilitiesCurrent Liabilities, Current USD 2.74M 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 123,834 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 971,500 2019-01-01 2019-12-31 2020 FY 10-K 2021-09-17 0001493152-21-022984
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 100,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-04-14 0001493152-23-012267
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -43,687 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -262,897 2020-01-01 2020-12-31 2020 FY 10-K 2021-09-17 0001493152-21-022984
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -752,670 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -752,670 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -167,047 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-13 0001493152-22-013375
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -167,712 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap OfficersCompensation Salary and Wage, Officer, Excluding Cost of Good and Service Sold USD 68,450 2020-01-01 2020-06-30 2020 Q2 10-Q 2021-09-09 0001493152-21-022270
us-gaap OperatingExpenses Operating Expenses USD 584,958 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -584,958 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 13.95M 2023-12-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap OperatingLossCarryforwardsValuationAllowance Operating Loss Carryforwards, Valuation Allowance USD 2.93M 2023-12-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap OtherIncome Other Income USD 100,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001493152-21-027976
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 100,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-04-14 0001493152-23-012267
us-gaap PaymentsForRent Payments for Rent USD 22,168 2020-01-01 2020-12-31 2020 FY 10-K 2021-09-17 0001493152-21-022984
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 23,500 2019-01-01 2019-12-31 2020 FY 10-K 2021-09-17 0001493152-21-022984
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD 3,548 2022-01-01 2022-12-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 7.44M 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 30,234 2023-12-31 2024 Q1 10-Q 2025-01-10 0001493152-25-001743
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 7,240 2021-09-30 2021 Q3 10-Q 2021-11-12 0001493152-21-027976
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 75,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 100,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 36,789 2023-01-01 2023-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 971,500 2019-01-01 2019-12-31 2020 FY 10-K 2021-09-17 0001493152-21-022984
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 55,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap ProceedsFromOtherShortTermDebt Proceeds from Other Short-term Debt USD 291,010 2023-01-01 2023-06-30 2024 Q2 10-Q 2025-01-10 0001493152-25-001776
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD -41,192 2023-01-01 2023-12-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap ProceedsFromSaleOfEquityMethodInvestments Proceeds from Sale of Equity Method Investments USD 100,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-04-14 0001493152-23-012267
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 100,000 2023-01-01 2023-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap ProfessionalFees Professional Fees USD 341,549 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -492,185 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-21 0001493152-22-033024
us-gaap RepaymentsOfShortTermDebt Repayments of Short-term Debt USD 6,166 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 14,090 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -17.05M 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap RoyaltyExpense Royalty Expense USD 100,000 2022-03-14 2024 Q1 10-Q 2025-01-10 0001493152-25-001743
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 20,697 2023-01-01 2023-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested USD 1.5 2021-12-31 2022 Q3 10-Q 2022-11-21 0001493152-22-033024
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments USD 0 2022-08-09 2022-08-10 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2019-01-01 2019-12-31 2020 FY 10-K 2021-09-17 0001493152-21-022984
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.95 2022-08-09 2022-08-10 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.029 2022-08-09 2022-08-10 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 2.27 2022-06-30 2022 Q2 10-Q 2022-08-16 0001493152-22-023207
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 2.67M 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 0.62 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 3.96M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-21 0001493152-22-033024
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 550,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-16 0001493152-22-006994
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 770,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.5 2023-01-01 2023-12-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 770,000 2022-12-31 2022 FY 10-K 2023-04-14 0001493152-23-012267
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 2.27 2022-06-30 2022 Q2 10-Q 2022-08-16 0001493152-22-023207
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 2.67M 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 0.62 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 1.85 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-16 0001493152-22-006994
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 0.25 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-16 0001493152-22-006994
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0.25 2019-01-01 2019-12-31 2020 FY 10-K 2021-09-17 0001493152-21-022984
us-gaap SharesIssued Shares, Issued shares 0 2023-09-30 2023 Q3 10-Q 2023-11-14 0001493152-23-040951
us-gaap ShortTermBankLoansAndNotesPayable Short-term Bank Loans and Notes Payable USD 12,546 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap ShortTermBorrowings Short-term Debt USD 12,546 2024-06-30 2024 Q2 10-Q 2025-01-10 0001493152-25-001776
us-gaap ShortTermNonBankLoansAndNotesPayable Short-term Non-bank Loans and Notes Payable USD 55,000 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -2.65M 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap StockIssued1 Stock Issued USD 83,526 2023-01-01 2023-12-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 54,267 2023-01-01 2023-12-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 35,624 2024-07-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 300,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 50,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-10-21 0001493152-24-041809
us-gaap TransferToInvestments Transfer to Investments USD 395,833 2019-01-01 2019-12-31 2020 FY 10-K 2021-09-17 0001493152-21-022984
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 34.33M 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 17.66M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-16 0001493152-22-006994
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 34.33M 2024-01-01 2024-09-30 2024 Q3 10-Q 2025-01-10 0001493152-25-001779

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →